Antiarrhythmic effects of preconditioning in anaesthetised dogs and rats
- PMID: 1446318
- DOI: 10.1093/cvr/26.5.487
Antiarrhythmic effects of preconditioning in anaesthetised dogs and rats
Abstract
Objective: The aim was to determine the relationship of the duration of short coronary artery occlusions and of the reperfusion period to the extent of the antiarrhythmic effect of preconditioning.
Methods: A prolonged occlusion of a coronary artery in 102 anaesthetised rats and 55 anaesthetised dogs was preceded by a variable number of preconditioning coronary artery occlusions, of varying duration and with variable reperfusion periods between them and the prolonged occlusion.
Results: Preconditioning in both species reduced the severity of ischaemia induced arrhythmias, epicardial ST segment changes, and alterations in the degree of inhomogeneity of conduction during a subsequent prolonged coronary artery occlusion, provided that the reperfusion time was less than 30 min (in rats) and 1 h (in dogs). This antiarrhythmic effect of preconditioning was marked; eg, in dogs following two preconditioning occlusions survival from a combined ischaemia-reperfusion insult was 40% (cf, 0% in the controls).
Conclusions: Short preconditioning periods of myocardial ischaemia protect the myocardium against the arrhythmogenic effects of a more prolonged occlusion. The optimum time for this preconditioning occlusion in rats is 3 min and protection is still apparent 30 min later. In dogs, the protective effect is especially clear with two short (5 min) coronary artery occlusions. The protection in this species lasts for less than 1 h.
Similar articles
-
Preconditioning of the ischaemic myocardium; involvement of the L-arginine nitric oxide pathway.Br J Pharmacol. 1992 Nov;107(3):648-52. doi: 10.1111/j.1476-5381.1992.tb14501.x. Br J Pharmacol. 1992. PMID: 1472963 Free PMC article.
-
Attenuation of the antiarrhythmic effects of ischaemic preconditioning by blockade of bradykinin B2 receptors.Br J Pharmacol. 1994 Dec;113(4):1167-72. doi: 10.1111/j.1476-5381.1994.tb17120.x. Br J Pharmacol. 1994. PMID: 7534181 Free PMC article.
-
Protective effects of preconditioning of the ischaemic myocardium involve cyclo-oxygenase products.Cardiovasc Res. 1990 Dec;24(12):1020-3. doi: 10.1093/cvr/24.12.1020. Cardiovasc Res. 1990. PMID: 2129022
-
Pronounced antiarrhythmic effects of ischemic preconditioning.Cardioscience. 1994 Mar;5(1):9-18. Cardioscience. 1994. PMID: 8204800 Review.
-
[Reperfusion and postconditioning in acute ST segment elevation myocardial infarction. A new paradigm for the treatment of acute myocardial infarction. From bench to bedside?].Arch Cardiol Mex. 2006 Oct-Dec;76 Suppl 4:S76-101. Arch Cardiol Mex. 2006. PMID: 17469337 Review. Spanish.
Cited by
-
Regulation of gap junctions by nitric oxide influences the generation of arrhythmias resulting from acute ischemia and reperfusion in vivo.Front Pharmacol. 2013 Jun 14;4:76. doi: 10.3389/fphar.2013.00076. eCollection 2013. Front Pharmacol. 2013. PMID: 23785332 Free PMC article.
-
Effects and interaction, of cariporide and preconditioning on cardiac arrhythmias and infarction in rat in vivo.Br J Pharmacol. 1999 Jun;127(4):1048-55. doi: 10.1038/sj.bjp.0702566. Br J Pharmacol. 1999. PMID: 10433514 Free PMC article.
-
Role of ABCA1 in Cardiovascular Disease.J Pers Med. 2022 Jun 20;12(6):1010. doi: 10.3390/jpm12061010. J Pers Med. 2022. PMID: 35743794 Free PMC article. Review.
-
Delay by a calcium antagonist, amlodipine, of the onset of primary ventricular fibrillation in myocardial ischemia.Cardiovasc Drugs Ther. 1996 Sep;10(4):447-54. doi: 10.1007/BF00051109. Cardiovasc Drugs Ther. 1996. PMID: 8924058
-
Prevention by an inhibitor of the L-arginine-nitric oxide pathway of the antiarrhythmic effects of bradykinin in anaesthetized dogs.Br J Pharmacol. 1993 Sep;110(1):18-9. doi: 10.1111/j.1476-5381.1993.tb13764.x. Br J Pharmacol. 1993. PMID: 7693277 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical